Ketamine in Preclinical Memory Deficit Models for Schizophrenia: Insights from Suárez Santiago et al. (2023)
Introduction In a 2023 study published in Behavioral Pharmacology, Suárez Santiago and colleagues investigated the use of ketamine as a […]
Introduction In a 2023 study published in Behavioral Pharmacology, Suárez Santiago and colleagues investigated the use of ketamine as a […]
Introduction Schizophrenia is a challenging mental illness that can cause problems with memory and thinking. Researchers like Dr. Suárez Santiago
Introduction In a 2022 commentary in the American Journal of Psychiatry, Dr. Ned H. Kalin highlights the pressing need to
Introduction Alcohol and cannabis are commonly used substances, but they can lead to serious health problems when abused. Dr. Ned
Introduction Eating disorders such as anorexia nervosa and binge eating disorder are notoriously difficult to treat. In their 2022 publication
Introduction Eating disorders like anorexia and binge eating can be tough to treat, and current therapies don’t always work for
Introduction: Peyrovian et al.’s 2020 review in the Journal of Psychiatric Research summarizes registered clinical trials evaluating ketamine for psychiatric
Introduction: In 2020, Peyrovian and colleagues published an analysis of registered clinical trials investigating ketamine as a treatment for psychiatric
Introduction: Dr. Eric Lenze’s 2020 pilot study investigates ketamine’s safety and efficacy in older adults with treatment-resistant depression (TRD). This
Introduction: In 2020, Dr. Eric Lenze and his team launched a pilot study to explore how ketamine might help older